Back to search

Article

Albuminuria Changes as a surrogate endpoint in <i>Apolipoprotein L1</i> Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran Program

2026-06-08

Abstract excerpt

<h4>Importance</h4> Recently, proteinuria has been accepted as a surrogate end point for clinical trials in focal segmental glomerulosclerosis (FSGS) ang IgA nephropathy. However, proteinuria has not been evaluated in Apolipoprotein L1 (APOL1)-mediated kidney disease (AMKD). <h4>Methods</h4> Real world data (RWD) analysis of 128 patients of African ancestry with APOL1 high risk genotypes, without diabetes, enrol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
603b9298-2b8c-5cfd-bf95-07091a072b04
DOI
10.64898/2026.06.04.26354945
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Albuminuria Changes as a surrogate endpoint in <i>Apolipoprotein L1</i> Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran ProgramDOI 10.64898/2026.06.04.26354945
Select a neighboring publication to make it the new centre.